Stay updated on Margetuximab Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now presents the study record for the margetuximab expanded access program for patients with pretreated HER2-positive breast cancer, including program details, eligibility information, and study record dates.
    Difference
    20%
    Check dated 2026-11-07T12:58:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:42:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:01:02.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-10-17T16:46:50.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T17:11:12.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study content with an access-denied message and the standard site footer.
    Difference
    0.5%
    Check dated 2026-09-26T18:07:12.000Z thumbnail image

Stay in the know with updates to Margetuximab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Clinical Trial page.